4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-17-003205
SVP, Chief Business Officer sold 1,398 shares at $19.64 ($27,457)
From the SEC's structured data for this filing
Trades in this filing
Dahan Michel · SVP, Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-10-02 | Sale : show line 1 in the form | −1,398 | $19.64 | $27,457 | 95,826 | D |
| Open-market sales · 1,398 sh · avg $19.64 · $27,457 | ||||||
Loading xslF345X03/primarydocument.xml…